Amelioration of STZ-induced type 1 diabetic nephropathy by aqueous extract of Enicostemma littorale Blume and swertiamarin in rats
- PMID: 20229291
- DOI: 10.1007/s11010-010-0393-x
Amelioration of STZ-induced type 1 diabetic nephropathy by aqueous extract of Enicostemma littorale Blume and swertiamarin in rats
Abstract
Diabetic nephropathy (DN) is one of the foremost causes of renal failure and a primary cause of diabetes mellitus related death. Previously, we have reported that aqueous extract of Enicostemma littorale has potential antidiabetic activity. In the present study, we have investigated the effect of aqueous extract of E. littorale 1 g/kg, p.o. and swertiamarin 50 mg/kg, p.o. daily for 3 weeks in type 1 DN complications in SD rats. DN was assessed by serum urea, creatinine, lipid profile and water intake levels. Treatment with aqueous extract of E. littorale and swertiamarin significantly decreased serum urea and creatinine and other parameters associated with the development of DN in type 1 diabetic rats. We have also found considerable improvement in histology of glomerular function of aqueous extract of E. littorale and swertiamarin-treated animals.
Similar articles
-
Immunohistochemistry, histopathology, and biomarker studies of swertiamarin, a secoiridoid glycoside, prevents and protects streptozotocin-induced β-cell damage in Wistar rat pancreas.J Endocrinol Invest. 2015 Jun;38(6):669-84. doi: 10.1007/s40618-015-0243-5. Epub 2015 Mar 15. J Endocrinol Invest. 2015. PMID: 25770453
-
Evaluation of effect of aqueous extract of Enicostemma littorale Blume in streptozotocin-induced type 1 diabetic rats.Indian J Exp Biol. 2010 Jan;48(1):26-30. Indian J Exp Biol. 2010. PMID: 20358863
-
Effect of aqueous Enicostemma littorale Blume extract on key carbohydrate metabolic enzymes, lipid peroxides and antioxidants in alloxan-induced diabetic rats.J Pharm Pharmacol. 2005 Apr;57(4):497-503. doi: 10.1211/0022357055722. J Pharm Pharmacol. 2005. PMID: 15831211
-
The Molecular Targets of Swertiamarin and its Derivatives Confer Anti- Diabetic and Anti-Hyperlipidemic Effects.Curr Drug Targets. 2018;19(16):1958-1967. doi: 10.2174/1389450119666180406113428. Curr Drug Targets. 2018. PMID: 29623834 Review.
-
Chemistry, Pharmacology and Therapeutic Potential of Swertiamarin - A Promising Natural Lead for New Drug Discovery and Development.Drug Des Devel Ther. 2021 Jun 21;15:2721-2746. doi: 10.2147/DDDT.S299753. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34188450 Free PMC article.
Cited by
-
Immunohistochemistry, histopathology, and biomarker studies of swertiamarin, a secoiridoid glycoside, prevents and protects streptozotocin-induced β-cell damage in Wistar rat pancreas.J Endocrinol Invest. 2015 Jun;38(6):669-84. doi: 10.1007/s40618-015-0243-5. Epub 2015 Mar 15. J Endocrinol Invest. 2015. PMID: 25770453
-
Investigation of phytoconstituents of Enicostemma littorale as potential glucokinase activators through molecular docking for the treatment of type 2 diabetes mellitus.In Silico Pharmacol. 2021 Dec 2;10(1):1. doi: 10.1007/s40203-021-00116-8. eCollection 2022. In Silico Pharmacol. 2021. PMID: 34926125 Free PMC article.
-
Ameliorative Effects of Isoeugenol and Eugenol against Impaired Nerve Function and Inflammatory and Oxidative Mediators in Diabetic Neuropathic Rats.Biomedicines. 2023 Apr 18;11(4):1203. doi: 10.3390/biomedicines11041203. Biomedicines. 2023. PMID: 37189822 Free PMC article.
-
Dissolving Microneedle Transdermal Patch Loaded with Nanoliposomes of for the Management of Type II Diabetes.ACS Omega. 2025 Jun 16;10(25):26468-26477. doi: 10.1021/acsomega.4c11677. eCollection 2025 Jul 1. ACS Omega. 2025. PMID: 40621046 Free PMC article.
-
Decrease in serum matrix metalloproteinase-9 and matrix metalloproteinase-3 levels in Zucker fa/fa obese rats after treatment with swertiamarin.Exp Clin Cardiol. 2012 Spring;17(1):12-6. Exp Clin Cardiol. 2012. PMID: 23204894 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical